Argenx Launches $750 Million Global Offering
2023年7月18日 - 5:58AM
Dow Jones News
By Sabela Ojea
Argenx said Monday that it is offering $750 million of ordinary
shares.
The biotechnology company said the offering will be comprised of
ordinary shares represented by American Depository Shares in the
U.S. and other countries outside the European Economic Area, and a
simultaneous private placement of ordinary shares in the European
Economic Area and the U.K.
The company's shares ended the trading session on Monday up 28%
at $484.43.
Argenx's offering comes a month after the company said it
received Food and Drug Administration approval for its Vyvgart
Hytrulo injection to treat certain adult patients with generalized
myasthenia gravis, a chronic autoimmune, neuromuscular disease that
can weaken skeletal muscles.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
July 17, 2023 16:43 ET (20:43 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
argenx (NASDAQ:ARGX)
過去 株価チャート
から 5 2024 まで 6 2024
argenx (NASDAQ:ARGX)
過去 株価チャート
から 6 2023 まで 6 2024
